Research in sleep-disordered breathing (SDB)

Through ResMed’s strong partnerships within the global medical community, we are committed to supporting and engaging in SDB research that:

• leverages real-world evidence (RWE) to gain new perspectives on SDB patients’ responses and outcomes
• investigates the benefits of digital health technologies to support therapy adherence
• evaluates the efficacy of OSA therapies

Real-world evidence studies focusing on PAP therapy for OSA patients

ALASKA study outcomes: first publication¹

The first outcomes from the ALASKA study showed that it’s important to consider patient phenotyping and personalised care when developing integrated sleep apnoea management strategies.

Download infographic

ALASKA study results: second and third publication^2,3

Outcomes from the ALASKA study found that not only does the chance of survival increase by 39% if PAP therapy is continued for the first year, there are also survival benefits for patients who resume CPAP after an initial discontinuation.

Download infographic

PATHOS: Prevalence and predictors of PAP usage in OSA⁴

This German retrospective study of 22,317 obstructive sleep apnoea patientsfound only 55% of all eligible patients were prescribed PAP therapy. It highlighted the significant predictors of PAP treatment.

Download infographic (NO LINK)

Obstructive sleep apnoea research

connected-health-for-sleep-disorders-resmed

Sleep apnoea and digital connected health

Improved compliance, greater efficiencies, higher quality of care – here is some of the latest research that provides evidence of these results.

Narval CC**

There’s a growing body of clinical research that demonstrates the efficacy and compliance of mandibular repositioning devices (MRDs) in treating obstructive sleep apnoea and snoring.

Research in ASV therapy

There is increasing evidence to suggest that adaptive servo-ventilation (ASV) therapy can be effective in the eligible central sleep apnoea (CSA) population. We’ve collated the key clinical studies and guidelines on the use of ASV to give you the big picture of this therapy in practice and its potential benefits for patients.

Support for investigator initiated research

ResMed believes in the need to support ethical, independent clinical research, conducted by qualified third-party investigators.